Guidelines

Study examines whether treating women and their male partners results in lower rates of bacterial vaginosis recurrence compared to treating women only. 

The trick may be about appropriate cumulative dosage.

The CDSS should provide a concise list of issues for pharmacists to follow up on and automatically calculate any risk scores embedded within the CDSS analysis.

Genetically determined in all ethnicities, some researchers are now suggesting all patients should be measured for lipoprotein (a) levels at least once in their lifetime.

University of Toronto researchers identify link between low placental growth factor levels and risk of early preterm birth.

How to introduce GLP-1 receptor agonists and GLP-1/GIP dual agonists in the clinic.

Get the info you need on this new product, part of our drug news roundup for February.

While safeguarding patients’ health information is a must, there is also a necessary time to share it.